1-16 of 16
M Smith
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Correction: Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study

Free
Kathryn C. Edwards, Asia Khan, Eva Sharma, Lanqing Wang, June Feng, Benjamin C. Blount, Connie S. Sosnoff, Danielle M. Smith, Maciej L. Goniewicz, Jennifer Pearson, Andrea C. Villanti, Cristine D. Delnevo, Michelle T. Bover-Manderski, Dorothy K. Hatsukami, Raymond Niaura, Colm Everard, Heather L. Kimmel, Kara Duffy, Brian L. Rostron, Arseima Y. Del Valle-Pinero, Dana M. van Bemmel, Cassandra A. Stanton, Andrew Hyland
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2025) 34 (1): 206.
https://doi.org/10.1158/1055-9965.EPI-24-1664
Published: 09 January 2025
View articletitled, Correction: Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Open the PDF for Correction: Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study in another window
Journal Articles

Correction: Urinary Cotinine and Cotinine + Trans-3′-Hydroxycotinine (TNE-2) Cut-points for Distinguishing Tobacco Use from Nonuse in the United States: PATH Study (2013–2014)

Free
Kathryn C. Edwards, Tasmia Naz, Cassandra A. Stanton, Maciej L. Goniewicz, Dorothy K. Hatsukami, Danielle M. Smith, Lanqing Wang, Andrea Villanti, Jennifer Pearson, Benjamin C. Blount, Maansi Bansal-Travers, June Feng, Raymond Niaura, Michelle T. Bover Manderski, Connie S. Sosnoff, Cristine D. Delnevo, Kara Duffy, Arseima Y. Del Valle-Pinero, Brian L. Rostron, Colm Everard, Heather L. Kimmel, Dana M. van Bemmel, Andrew Hyland
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2025) 34 (1): 208.
https://doi.org/10.1158/1055-9965.EPI-24-1668
Published: 09 January 2025
View articletitled, Correction: Urinary Cotinine and Cotinine + Trans-3′-Hydroxycotinine (TNE-2) Cut-points for Distinguishing Tobacco Use from Nonuse in the United States: PATH Study (2013–2014)
Open the PDF for Correction: Urinary Cotinine and Cotinine + Trans-3′-Hydroxycotinine (TNE-2) Cut-points for Distinguishing Tobacco Use from Nonuse in the United States: PATH Study (2013–2014) in another window
Journal Articles

Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study

Available to Purchase
Kathryn C. Edwards, Asia Khan, Eva Sharma, Lanqing Wang, June Feng, Benjamin C. Blount, Connie S. Sosnoff, Danielle M. Smith, Maciej L. Goniewicz, Jennifer Pearson, Andrea C. Villanti, Cristine D. Delnevo, Michelle T. Bover-Manderski, Dorothy K. Hatsukami, Raymond Niaura, Colm Everard, Heather L. Kimmel, Kara Duffy, Brian L. Rostron, Arseima Y. Del Valle-Pinero, Dana M. van Bemmel, Cassandra A. Stanton, Andrew Hyland
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2023) 32 (9): 1233–1241.
https://doi.org/10.1158/1055-9965.EPI-22-1228
Published: 01 September 2023
View articletitled, Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Open the PDF for Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study in another window
Includes: Supplementary data
Journal Articles

Abstract B042: Understanding unmet needs of adult survivors of childhood cancer in California’s Salinas Valley: A community-academic partnership to develop programs for families after cancer treatment

Free
Stephanie M. Smith, Caroline Pecos-Duarte, Evelyn Tolamatl Ariceaga, Elle Billman, Anmol Teer, Catherine Benedict, Mary Smith, Sandy Montes, Esmeralda Rivera, Daniela Ramirez, Heidi Boynton, Lidia Schapira
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2023) 32 (1_Supplement): B042.
https://doi.org/10.1158/1538-7755.DISP22-B042
Published: 01 January 2023
View articletitled, Abstract B042: Understanding unmet needs of adult survivors of childhood cancer in California’s Salinas Valley: A community-academic partnership to develop programs for families after cancer treatment
Journal Articles

Urinary Cotinine and Cotinine + Trans-3′-Hydroxycotinine (TNE-2) Cut-points for Distinguishing Tobacco Use from Nonuse in the United States: PATH Study (2013–2014)

Available to Purchase
Kathryn C. Edwards, Tasmia Naz, Cassandra A. Stanton, Maciej L. Goniewicz, Dorothy K. Hatsukami, Danielle M. Smith, Lanqing Wang, Andrea Villanti, Jennifer Pearson, Benjamin C. Blount, Maansi Bansal-Travers, June Feng, Raymond Niaura, Michelle T. Bover Manderski, Connie S. Sosnoff, Cristine D. Delnevo, Kara Duffy, Arseima Y. Del Valle-Pinero, Brian L. Rostron, Colm Everard, Heather L. Kimmel, Dana M. van Bemmel, Andrew Hyland
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2021) 30 (6): 1175–1184.
https://doi.org/10.1158/1055-9965.EPI-20-0997
Published: 01 June 2021
View articletitled, Urinary Cotinine and Cotinine + Trans-3′-Hydroxycotinine (TNE-2) Cut-points for Distinguishing Tobacco Use from Nonuse in the United States: PATH Study (2013–2014)
Open the PDF for Urinary Cotinine and Cotinine + Trans-3′-Hydroxycotinine (TNE-2) Cut-points for Distinguishing Tobacco Use from Nonuse in the United States: PATH Study (2013–2014) in another window
Includes: Supplementary data
Journal Articles

Abstract C76: Mechanistic implications of advanced glycation end-products to prostate cancer and racial disparity

Free
Danzell M. Smith, Dion Foster, Van Phan, Victoria J. Findlay, Lourdes M. Nogueira, Laura Spruill, Mahtabuddin Ahmed, Judith D. Salley, Marvella E. Ford, David P. Turner
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2016) 25 (3_Supplement): C76.
https://doi.org/10.1158/1538-7755.DISP15-C76
Published: 01 March 2016
View articletitled, Abstract C76: Mechanistic implications of advanced glycation end-products to prostate cancer and racial disparity
Journal Articles

Abstract C65: Defining the implications of sugar derived metabolites (AGEs) to tamoxifen resistance and breast cancer disparity: Is it a question of lifestyle?

Free
Katherine R. Walter, Danzell M. Smith, Van Phan, Laura spruill, Marvella E. Ford, Victoria J. Findlay, David P. Turner
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2016) 25 (3_Supplement): C65.
https://doi.org/10.1158/1538-7755.DISP15-C65
Published: 01 March 2016
View articletitled, Abstract C65: Defining the implications of sugar derived metabolites (AGEs) to tamoxifen resistance and breast cancer disparity: Is it a question of lifestyle?
Journal Articles

A Population-Based Study of Prevalence and Adherence Trends in Average Risk Colorectal Cancer Screening, 1997 to 2008

Free
Pamela S. Sinicrope, Ellen L. Goode, Paul J. Limburg, Sally W. Vernon, Joseph B. Wick, Christi A. Patten, Paul A. Decker, Andrew C. Hanson, Christina M. Smith, Timothy J. Beebe, Frank A. Sinicrope, Noralane M. Lindor, Tabetha A. Brockman, L. Joseph Melton, III, Gloria M. Petersen
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2012) 21 (2): 347–350.
https://doi.org/10.1158/1055-9965.EPI-11-0818
Published: 06 February 2012
View articletitled, A Population-Based Study of Prevalence and Adherence Trends in Average Risk Colorectal Cancer Screening, 1997 to 2008
Open the PDF for A Population-Based Study of Prevalence and Adherence Trends in Average Risk Colorectal Cancer Screening, 1997 to 2008 in another window
Journal Articles

Does Pretreatment Seropositivity to Human Papillomavirus Have Prognostic Significance for Head and Neck Cancers?

Free
Elaine M. Smith, Linda M. Rubenstein, Justine M. Ritchie, John H. Lee, Thomas H. Haugen, Eva Hamsikova, Lubomir P. Turek
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2008) 17 (8): 2087–2096.
https://doi.org/10.1158/1055-9965.EPI-08-0054
Published: 14 August 2008
View articletitled, Does Pretreatment Seropositivity to Human Papillomavirus Have Prognostic Significance for Head and Neck Cancers?
Open the PDF for Does Pretreatment Seropositivity to Human Papillomavirus Have Prognostic Significance for Head and Neck Cancers? in another window
Journal Articles

Association between p53 and Human Papillomavirus in Head and Neck Cancer Survival

Free
Elaine M. Smith, Donghong Wang, Linda M. Rubenstein, William A. Morris, Lubomir P. Turek, Thomas H. Haugen
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2008) 17 (2): 421–427.
https://doi.org/10.1158/1055-9965.EPI-07-2597
Published: 11 February 2008
View articletitled, Association between p53 and Human Papillomavirus in Head and Neck Cancer Survival
Open the PDF for Association between p53 and Human Papillomavirus in Head and Neck Cancer Survival in another window
Journal Articles

Quantitative Fluorescence Imaging Analysis for Cancer Biomarker Discovery: Application to β-Catenin in Archived Prostate Specimens

Free
Dali Huang, George P. Casale, Jun Tian, Nizar K. Wehbi, Neil A. Abrahams, Zahid Kaleem, Lynette M. Smith, Sonny L. Johansson, Johny E. Elkahwaji, George P. Hemstreet, III
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2007) 16 (7): 1371–1381.
https://doi.org/10.1158/1055-9965.EPI-06-0718
Published: 12 July 2007
View articletitled, Quantitative Fluorescence Imaging Analysis for Cancer Biomarker Discovery: Application to β-Catenin in Archived Prostate Specimens
Open the PDF for Quantitative Fluorescence Imaging Analysis for Cancer Biomarker Discovery: Application to β-Catenin in Archived Prostate Specimens in another window
Journal Articles

Validation of quantitative fluorescence imaging analysis (QFIA) of β-catenin in archived prostate tissues for cancer biomarker discovery.

Free
George P. Casale, Dali Huang, Jun Tian, Nizar K. Wehbi, Neil A. Abrahams, Zahid Kaleem, Lynette M. Smith, Sonny L. Johansson, Johny E. Elkahwaji, George P. Hemstreet, III
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2006) 15 (12_Supplement): B16.
Published: 01 December 2006
View articletitled, Validation of quantitative fluorescence imaging analysis (QFIA) of β-catenin in archived prostate tissues for cancer biomarker discovery.
Journal Articles

Alcohol Dehydrogenase 3 and Risk of Squamous Cell Carcinomas of the Head and Neck

Free
Donghong Wang, Justine M. Ritchie, Elaine M. Smith, Zugui Zhang, Lubomir P. Turek, Thomas H. Haugen
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2005) 14 (3): 626–632.
https://doi.org/10.1158/1055-9965.EPI-04-0343
Published: 14 March 2005
View articletitled, Alcohol Dehydrogenase 3 and Risk of Squamous Cell Carcinomas of the Head and Neck
Open the PDF for Alcohol Dehydrogenase 3 and Risk of Squamous Cell Carcinomas of the Head and Neck in another window
Journal Articles

Tannic Acid Potently Inhibits Tumor Cell Proteasome Activity, Increases p27 and Bax Expression, and Induces G1 Arrest and Apoptosis

Free
Sangkil Nam, David M. Smith, Q. Ping Dou
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2001) 10 (10): 1083–1088.
Published: 01 October 2001
View articletitled, Tannic Acid Potently Inhibits Tumor Cell Proteasome Activity, Increases p27 and Bax Expression, and Induces G1 Arrest and Apoptosis
Open the PDF for Tannic Acid Potently Inhibits Tumor Cell Proteasome Activity, Increases p27 and Bax Expression, and Induces G1 Arrest and Apoptosis in another window
Journal Articles

Research issues in cancer survivorship: report of a workshop sponsored by the Office of Cancer Survivorship, National Cancer Institute.

Free
A T Meadows, C Varricchio, K Crosson, L Harlan, P McCormick, E Nealon, M Smith, R Ungerleider
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (1998) 7 (12): 1145–1151.
Published: 01 December 1998
View articletitled, Research issues in cancer survivorship: report of a workshop sponsored by the Office of Cancer Survivorship, National Cancer Institute.
Open the PDF for Research issues in cancer survivorship: report of a workshop sponsored by the Office of Cancer Survivorship, National Cancer Institute. in another window
Journal Articles

Inherited glutathione-S-transferase deficiency is a risk factor for pulmonary asbestosis.

Free
C M Smith, K T Kelsey, J K Wiencke, K Leyden, S Levin, D C Christiani
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (1994) 3 (6): 471–477.
Published: 01 September 1994
View articletitled, Inherited glutathione-S-transferase deficiency is a risk factor for pulmonary asbestosis.
Open the PDF for Inherited glutathione-S-transferase deficiency is a risk factor for pulmonary asbestosis. in another window